Insider trading · Q3 2026 · CIK 1077183

Neogenomics Inc (NEO) insider trading.

Name: Neogenomics Inc insider transactions, Q3 2026
Creator: U.S. Securities and Exchange Commission

In Q3 2026, insiders at Neogenomics Inc reported 4 non-derivative transactions on 3 Forms 3, 4 and 5: 0 open-market purchases and 1 sale worth $321K.

Transactions: 4
Purchases (P): 0
Sales (S): 1
Net shares, P minus S: -20,000
Insiders: 3
Last filed: 2026-09-03

Insiders

Insider	Relationship	Transactions	Sales
Stone Warren	Officer · Pres & Chief Operating Officer	2	0
Olivo Alicia C	Officer · EVP, GC & Business Development	1	0
Aunan Greg D	Officer · Chief Accounting Officer	1	1

Transactions

4 non-derivative rows, newest transaction first. Shares and prices as filed.
Date	Insider	Code	Shares	Price	Owned after	Filing
2026-09-01	Olivo Alicia C	F (D)	2,692	$0	90,875	Form 4
2026-08-21	Stone Warren	M (A)	28,106	$0	192,138	Form 4
2026-08-21	Stone Warren	F (D)	11,060	$0	181,078	Form 4
2026-08-04	Aunan Greg D	S (D)	20,000	$16.07	5,153	Form 4

Transaction codes in this quarter

F: 2 M: 1 S: 1

Get NEO insider transactions through the API

Request with your API key

curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1077183&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · NEO company page · Neogenomics Inc on SEC.gov

Questions

Are insiders buying or selling Neogenomics Inc (NEO)?

In Q3 2026, insiders at Neogenomics Inc reported 4 non-derivative transactions on 3 Forms 3, 4 and 5: 0 open-market purchases and 1 sale worth $321K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Neogenomics Inc insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/neo.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.